Skip to content

Amway delves deep into gut microbiome and digital tech with new Singapore hub

This partnership between Amway and the Singapore Economic Development Board (EDB) aims to bring together scientists and experts across the supply chain to address the evolving needs of regional and global consumers.

“The idea of ​​the Hub is to create more agile cross-functional teams to solve issues faced by consumers much more compellingly beyond a R&D standpoint. We want to create go-to-market innovations that are far more all-encompassing,”Asha Gupta, Amway’s Regional President, Asia and Chief Strategy & Corporate Development Officer, told NutraIngredients-Asia​.

Amway will be working alongside various local institutions, such as Agency for Science, Technology and Research (A*STAR) and Asian Microbiome Library (AMILI), to leverage their insights and technologies to elevate its entire portfolio.

“We are eager to conduct more research and trials on the gut microbiome, which AMILI is doing great work on. The work of the Hub is to take our scientific innovations and expertise, and translate that into strong market experiences,” said Gupta.

Through the Hub, Amway will also be expanding its flagship supplement brand Nutrilite’s product lines, particularly those related to gut health such as prebiotics and probiotics.

This is on top of Amway’s existing project in South Korea, where the company has invested in the study of the gut microbiome to enhance its understanding and delivery of personalized nutrition.

“Instead of general vitamins and probiotics, we are able to tweak supplement solutions based on an individual’s needs. Personalization is in varied stages of development in different countries — some consumers are already seeking hyper-personalised offerings, while some have not reached that stage yet. But this is certainly an area that we are looking to push ahead in the next few years,” Gupta added.

.